After getting a response from a Sprout Health agent via email, he told me that Sprout Health offers both semaglutide and tirzepatide
If you have questions or need support in navigating your options, MedHealth360 is here to help
The SURPASS-4 trial showed that tirzepatide was associated with reduced progression of albuminuria compared to insulin glargine in patients with type 2 diabetes, suggesting potential kidney benefits
Maintenance doses vary widely due to differences in body composition, GLP-1 receptor genetics, kidney and liver function, and individual metabolic rate
5,6 In a 12-week randomized trial, supplementation with 1,200 mg per day of berberine and 600 mg per day of cinnamon significantly reduced fasting blood glucose, HbA1c, and low-density lipoprotein (LDL) levels in patients with type 2 diabetes, without producing significant changes in body weight or BMI
But the demand has become so intense that the market exploded faster than pharmaceutical companies could keep up
